Multidisciplinary working group for interstitial lung disease in Thailand: Part 1-rationale in developing a guide to estimate the global disease and fibrotic extents on high-Resolution computed tomography

Authors

  • Wiwatana Tanomkiat, M.D. Department of Radiology, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand.
  • Chayanin Nitiwarangkul, M.D. Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Juntima Euathrongchit, M.D. Department of Radiology, Faculty of Medicine, Chiangmai University, Chiangmai, Thailand.
  • Phakphoom Thiravit, M.D. Department of Radiology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Thanisa Tongbai, M.D. Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Thitiporn Suwatanapongched, M.D. Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Keywords:

Interstitial lung disease, Fibrotic extent, Disease extent, Multidisciplinary discussion, Thailand

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Cosgrove GP, Schwarz MI. Approach to the evaluation and diagnosis of interstitial lung disease. In: Schwarz MI, King TE Jr., editors. Interstitial lung disease. 5th ed. Shelton (CT): People’s Medical Pub. House; 2011. p. 3-33.

Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Glob Health 2019;85:1-14. doi: 10.5334/aogh.2414.

Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, et al. Interstitial lung disease in India: results of a prospective registry. Am J Respir Crit Care Med 2017;195:801-13. doi: 10.1164/rccm.201607-1484OC.

Chai GT, Tan TC, Lee YS, Kaw GJ, Chuah KL, Lim YJ, et al. Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore. Singapore Med J 2020;61:302-7. doi: 10.11622/smedj.2019069.

Tanomkiat W, Areewattana N, Juthong S, Navaskulpong A, Siripaitoon B, Sarayut LG. High-resolution computed tomography (HRCT) disease patterns and survival times in patients with interstitial lung disease at a university tertiary hospital in southern Thailand from 2006 to 2012. Asian J Med Radiol Res. Forthcoming 2022.

Wallis A, Spinks K. The diagnosis and management of interstitial lung diseases. BMJ 2015;350:h2072. doi: 10.1136/bmj.h2072.

Baydur A. Pulmonary physiology in interstitial lung disease: recent developments in diagnostic and prognostic implications. Curr Opin Pulm Med 1996;2:370-5. doi: 10.1097/00063198-199609000-00005.

Lynch DA. Radiologic differential diagnosis of diffuse lung disease. In: Lynch DA , Newell DJ Jr, Lee JS, editors. Imaging of diffuse lung disease. Hamilton (Ontario): B.C. Decker; 2000: p. 35-56.

Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clin Proc 2019;94:309-25. doi: 10.1016/j.mayocp.2018.09.002.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198:e44-68. doi: 10.1164/rccm.201807-1255ST.

Hutchinson JP, McKeever TM, Fogarty AW, Navaratnam V, Hubbard RB. Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008. Eur Respir J 2016;48:1453-61. doi: 10.1183/13993003.00378-2016.

Powell HA, Tata LJ, Baldwin DR, Stanley RA, Khakwani A, Hubbard RB. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Thorax 2013;68:826-34. doi: 10.1136/thoraxjnl-2012-203123.

Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733–48. doi: 10.1164/rccm.201308-1483ST.

Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 2018;6:138–53. doi: 10.1016/S2213-2600(17)30433-2.

Prasad JD, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Lake F, et al. The interstitial lung disease multidisciplinary meeting: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology 2017;22:1459–72. doi: 10.1111/resp.13163.

Flaherty KR, King TE Jr, Raghu G, Lynch JP 3rd, Colby TV, Travis WD, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004;170:904-10. doi: 10.1164/rccm.200402-147OC.

Wijsenbeek M, Kreuter M, Olson A, Fischer A, Bendstrup E, Wells CD, et al. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin 2019;35:2015-24. doi: 10.1080/03007995.2019.1647040.

Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006;3:285-92. doi: 10.1513/pats.200601-005TK.

Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2013;42:750-7. doi: 10.1183/09031936.00131912.

Traila D, Oancea C, Tudorache E, Mladinescu OF, Timar B, Tudorache V. Clinical profile of unclassifiable interstitial lung disease: comparison with chronic fibrosing idiopathic interstitial pneumonias. J Int Med Res 2018;46:448-56. doi: 10.1177/0300060517719767.

King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-92. doi: 10.1056/NEJMoa1402582.

Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-82. doi: 10.1056/NEJMoa1402584.

Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, et al. Nintedanib for systemic sclerosis–associated interstitial lung disease. N Engl J Med 2019;380:2518-28. doi: 10.1056/NEJMoa1903076.

Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, et al. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 2020;8: 453-60. doi: 10.1016/S2213-2600(20)30036-9.

Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014;145:723–8. doi: 10.1378/chest.13-1474.

Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143–8. doi: 10.1136/thorax.58.2.143.

Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35:1322–28. doi: 10.1183/09031936.00092309.

Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, et al. Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 2016;47:1767–75. doi: 10.1183/13993003.01565-2015.

Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008;177:1248-54. doi: 10.1164/rccm.200706-877OC.

Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, et al. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med 2017;127:51-6. doi: 10.1016/j.rmed.2017.04.012.

Sánchez RP, Fernández-Fabrellas E, Samper GJ, Montañana MLD, Vilar LN. Visual HRCT score to determine severity and prognosis of idiopathic pulmonary fibrosis. Int J Respir Pulm Med 2018;5:084. doi.org/10.23937/2378-3516/1410084.

Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin-section CT obtained at I 0-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997;169:977-83. doi: 10.2214/ajr.169.4.9308447.

Downloads

Published

2021-12-31

How to Cite

1.
Tanomkiat W, Nitiwarangkul (Thongprasert) C, Euathrongchit J, Thiravit P, Tongbai T, Suwatanapongched T. Multidisciplinary working group for interstitial lung disease in Thailand: Part 1-rationale in developing a guide to estimate the global disease and fibrotic extents on high-Resolution computed tomography. ASEAN J Radiol [Internet]. 2021Dec.31 [cited 2022May20];22(3):47-60. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/158

Issue

Section

ASEAN Movement in Radiology

Most read articles by the same author(s)

1 2 > >>